ABSTRACT
Attenuated Salmonella are useful oral vaccine vectors capable of carrying multiple heterologous antigen genes, but optimal expression of foreign antigens has not yet been achieved. We hypothesized that Salmonella phoPactivated genes, which are transcriptionally activated within antigen-processing macrophages, could prove useful for de- livery of heterologous antigens to the immune system. We have created a suicide vector that allows the stable chromosomal insertion of heterologous antigen genes within the phoPactivated gene C (pagC) of SalmoneUa and permits the expression of heterologous antigens as fusion proteins between the first 84 amino acids of PagC and the chosen antigen. The Escherichia coli phoA gene encoding alkaline phosphatase was cloned into this vector; the resultant plasmid was used to construct Salmonella typhimurium strains that express PagCalkaline phosphatase fusion proteins from a single chromosomal gene copy. Such strains were administered orally and i.p. as vaccines to BALB/c mice and compared with control strains expressing alkaline phosphatase constitutively. After 3 weeks, mouse sera were analyzed for IgG responses to S. typhimurium lipopolysaccharide and alkaline phosphatase. Remarkably, though all mice had comparable antibody responses to lipopolysaccharide, only mice immunized with strains bearing phoP-activated fusion genes had antibody responses to the heterologous antigen. We conclude that expression of a heterologous antigen from an S. typhimurium in vivo-induced promotor that is activated within macrophages markedly enhances the immunogenicity of a model antigen expressed from a single chromosomal gene copy.
Universal immunization would be greatly facilitated by the creation of multivalent oral vaccines capable of protecting individuals against multiple pathogens. Attenuated Salmonella have been widely investigated as live oral vaccine vectors capable of stimulating humoral, cell-mediated, and mucosal immunity in mammalian hosts (1) , but optimal expression of heterologous antigens within Salmonella has not yet been achieved (2) . In most vaccine strains, foreign immunogens have been constitutively expressed from plasmid-encoded antigen genes (3) (4) (5) (6) . Difficulties associated with these vaccines have included the instability of plasmids within mammalian hosts and toxic effects of overexpressed heterologous proteins on bacterial vectors, leading to poor immunogenicity despite high levels of antigen expression. To circumvent these problems, heterologous antigen genes have been inserted into specific attenuating loci within the Salmonella chromosome (2, (7) (8) (9) . Such strains rely upon the expression of a single gene copy rather than multicopy plasmid-encoded antigen genes. Although cytotoxic T-cell responses to such constructs have been demonstrated (8) , single chromosomal copies of heterologous antigens in Salmonella have not elicited significant humoral immune responses to date.
Bacterial genes expressed in vivo have been postulated to encode virulence determinants that may be important immunogens (10) . The ability of Salmonella to survive within mammalian macrophages is a prominent feature of Salmonella pathogenesis and correlates with virulence (11) (12) (13) , suggesting that essential bacterial survival strategies are operative within this antigen-processing cell. We hypothesized that expression of heterologous antigens from a Salmonella promotor specifically induced within macrophages and previously shown to control a Salmonella typhimurium virulence factor could provide an ideal means of in vivo expression and attenuation of a potential vaccine strain. Intracellular transcriptional activation of a chromosomal gene fusion between a virulence factor and a foreign antigen may lead to high levels of antigen expression in a manner temporally and physically ideal for the generation of an immune response. The Salmonella PhoP/PhoQ regulon is a bacterial two-component regulatory locus (11, 12) , similar to a family of histidine kinases (PhoQ) and transcriptional regulators (PhoP). This locus regulates multiple unlinked phoP-activated genes (the pag genes) (11, 13, 14) and phoPrepressed genes (theprg genes) (15) . PhoP-null S. typhimurium mutants are markedly attenuated for virulence in BALB/c mice (16, 17) , animals that serve as a useful model for the development of Salmonella-vectored vaccines. One important phenotype contributing to this attenuation is the impaired ,survival of PhoP-null organisms within mammalian macrophages (11, 16, 18) . We have demonstrated (19) that phoPactivated genes are specifically transcriptionally activated by >100-fold after phagocytosis by murine bone marrow-derived macrophages, but not by epithelial cells. In addition, phoPregulated gene products are among the most prominent bacterial products synthesized upon entry into mammalian macrophages (20) . pagC encodes a 188-amino acid outer membrane protein essential for full virulence of S. typhimurium in BALB/c mice, andpagC mutantS. typhimurium survive poorly within mouse macrophages (13) . We created a suicide vector that allows chromosomal insertion of heterologous antigen genes within the pagC locus in such a way that fusion proteins are generated between the first 84 amino acids of the PagC protein and the heterologous antigen of interest. We demonstrate that expression of a model antigen gene from a single chromosomal copy under control of phoP/phoQ is both attenuating and highly immunogenic. amino acid mixture (21) . pir-dependent suicide vectors were mobilized to the chromosome of Salmonella by conjugal transfer (22) . Agar plates for selection of S. typhimurium strains that had eliminated suicide vector sequences were modified Luria broth plates containing 10% (wt/vol) sucrose and no NaCl (23) . P22HTint bacteriophage transductions (24) were utilized to transfer some chromosomal genetic elements from wild-type to aroA-deleted Salmonella. PhoP-null strains were created (15) by using bacteriophage lysates grown on S. typhimurium AD154 (phoP12purB1744::TnlO) (the gift of E.
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Eisenstadt, Naval Medical Center, Bethesda).
Molecular Biology. DNA manipulations were performed as described (25) . PCRs used Taq polymerase (GeneAmp, Perkin-Elmer/Cetus). DNA hybridization analyses (26) employed 32P-radiolabeled DNA probes prepared by the randomprimer method (27) .
Mouse Studies. Female BALB/c mice (18-24 g, Charles River Breeding Laboratories) were used. Oral and i.p. inoculations were performed as described (15), by using four mice per group for LD5o determinations. Inoculum doses were confirmed by serial dilution and plating for colony forming units (cfu). Mice were bled via tail veins 3 weeks after immunization.
Western Blot Analysis and ELISAs. Whole bacterial protein lysates were prepared and separated by SDS/PAGE (28) . Western immunoblot analysis was performed (29) with a polyclonal rabbit antibody directed against alkaline phosphatase (gift of John Mekalanos, Harvard Medical School, Boston) and goat anti-rabbit secondary antibody conjugated to alkaline phosphatase (Sigma). Dot blots utilized a peroxidase-labeled goat anti-mouse antiserum and an enhanced chemiluminescent detection system (Amersham). ELISAs were performed (29) by using 96-well plates (Dynatech) coated with S. typhimurium lipopolysaccharide (LPS, Sigma) or purified E. coli alkaline phosphatase (Sigma). Phosphate-buffered saline containing 0.05% Tween 20 (Sigma) and 5% (wt/vol) dried milk was used as a blocking agent. Goat anti-mouse IgG conjugated to peroxidase and tetramethylbenzidine dihydrochloride substrate (Sigma) were used for detection. Reactions were stopped with 1 M H2SO4 and plates were read at 450 nm. IgG subclass determinations were performed similarly by using secondary antibodies to IgGl or IgG2a subclasses (Boehringer Mannheim).
RESULTS
Construction of a Suicide Vector pVAC468 for Chromosomal Insertion of Heterologous Antigen Genes Under phoP/phoQ Regulation. pVAC468 is a derivative of pGP704, an RP4 replicon that requires the pir-encoded protein for replication (30) . pGP704 was modified to include an -1.5-kb segment of S. typhimurium DNA containing the entire pagC locus. Subsequently, a 490-bp internal region ofpagC flanked by Cla I and Bgl II restriction endonuclease sites was replaced with a synthetic oligonucleotide polylinker, resulting in deletion of the DNA encoding the 104 C-terminal amino acids of the PagC protein. To allow positive selection for the loss of plasmid sequences by homologous recombination, the sacB gene of Bacillus subtilis, which encodes levan sucrase, was then cloned into this intermediary vector, yielding pVAC468 ( Fig.   1 ).
E. coli alkaline phosphatase was chosen as the initial antigen studied because it is easily detected enzymatically. Use by PCR from pRT291 (31) by using PCR primers engineered to create flanking EcoRV restriction endonuclease sites and, subsequently, cloned into the EcoRV site of pVAC468, yielding pVAC468-phoA. pVAC468-phoA was mobilized via conjugation into S. typhimunum CS019. Strains with homologous recombination of pVAC468-phoA at the pagC locus were recognized by plating on medium containing ampicillin. Subsequently, activation of the sacB gene at 30°C on low salt/high sucrose agar plates (23, 33) allowed recognition of strains that had spontaneously deleted plasmid sequences via a second homologous recombination event; such strains either reconstituted the wild-type pagC locus or had undergone replacement of the native locus with the pagCA490-phoA allele. Blot hybridization analysis of bacterial chromosomal DNA was used to differentiate between these two possibilities, and one strain of CS019 carrying the pagCA490-phoA fusion gene was designated strain LH491.
Strain LH491 bearing the engineered pagC-phoA fusion gene was evaluated as a prototype vaccine vector in BALB/c mice. LH491 was markedly attenuated for virulence in BALB/c mice when compared with the isogenic wild-type parent CS019 (intraperitoneal LD50 for CS019, <10 cfu per mouse; LD50 for LH491, 3.5 x 105 cfu per mouse). LH491 was demonstrated to contain an enzymatically active fusion protein, on indicator agar plates containing the substrate 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and in liquid-phase assays (21) . Expression of the fusion antigen was stable as measured by these techniques after 30 passages in vitro and 5 passages in mice (data not shown). The expression of the PagC-alkaline phosphatase antigen was phoP-regulated as measured by enzymatic activity (Fig. 2C) and Western blot analysis (Fig. 3)- (34) LH491 developed significant IgG responses to the heterologous antigen and vector ( Fig. 2 B and C) , as measured by ELISAs utilizing purified alkaline phosphatase and S. typhimurium LPS as antigen. IgG responses were also measurable by a dot blot immunoassay in which immune sera were incubated with nitrocellulose dot blots spotted with alkaline phosphatase. A positive reaction was detected at serum dilutions of at least 1:10,000 in all animals boosted i.p. 2-3 weeks after the primary immunization (Fig. 4) 12. antigen as measured by ELISAs. ELISAs were performed by applying immunized mouse sera in parallel to microtiter plates coated with alkaline phosphatase and developing these plates with secondary antibodies to total mouse IgG, IgGl, IgG2a, and IgG2b. IgG directed against alkaline phosphatase was primarily of the IgG2a and IgG2b subclasses; OD values for wells developed with anti-IgG2b were not significantly higher than control wells (data not shown). A representative experiment in which IgG2a was measured is shown in Fig. 5 .
To determine whether the apparent immunogenicity of the PagC-alkaline phosphatase fusion antigen was generalizable to otherphoP-regulated genes, alkaline phosphatase fusions to other recently identified phoP-activated genes, pagD and pagJ (14) , were studied. In this case, alkaline phosphatase fusions created by TnphoA mutagenesis in S. typhimurium CS019 were utilized. In vivo attenuation of these strains was comparable to that of LH491 (CS019pagD::TnphoA i.p. LD5o, 3 x 105 cfu per mouse; CS019pagJ::TnphoA i.p. LD50, 4 x 103 cfu per mouse). S. typhimurium strains expressing fusion proteins between PagD ( Fig. 2A) or PagJ (data not shown) and alkaline phosphatase were also able to induce an IgG response to alkaline phosphatase. Additionally, a previously isolated CS019 strain bearing apagCphoA gene fusion demonstrated to encode only the initial 11 amino acids of PagC (rather than the 84 N-terminal amino acids included in the engineered fusion protein carried by LH491) was also immunogenic. These data suggest that transcriptional acti- immunized i.p. with 2 x 104 cfu per mouse of strain LH491, given a booster injection 3 weeks later with 1 x 105 cfu per mouse, and bled 2 weeks later. Immune sera (mouse 1 through mouse 4) and a normal serum control were diluted 1:10,000 and incubated with nitrocellulose dot blots previously spotted with 10 ng of purified E. coli alkaline phosphatase. Detection was performed with a chemiluminescent peroxidase substrate and autoradiography. This is a representative experiment of four performed.
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Comparison ofphoP-Activated and phoP-Independent Promotors. Experiments were performed to show that phoP regulation, rather than the inherent immunogenicity of the model antigen or the degree of attenuation induced by the model antigen fusion protein, was important for generation of the antibody response. In these experiments, constitutively expressed alkaline phosphatase fusion proteins generated by TnphoA mutagenesis were utilized as controls. Two strains were chosen from an existing bank of 2000 TnphoA mutants created in S. typhimurium CS019 (14) . Alkaline phosphatase activity in these two control strains was demonstrated to be the result of single chromosomal copies ofphoA gene fusions that were independent of the PhoP regulon. One of these fusions (LH610) was chosen as it was expressed in vitro at levels similar to PagC; the second (LH617) was chosen as it was expressed at >10-fold greater levels than the PagC-alkaline phosphatase fusion antigen when measured by alkaline phosphatase activity (Fig. 2C) . Because enzymatic activity of individual alkaline phosphatase fusions may not necessarily correlate with amount of enzyme (antigen) present, Western blot analysis was performed on standardized aliquots ofwhole vaccine strain lysates to grossly quantitate the relative amounts of immunoreactive alkaline phosphatase present in each strain (Fig. 3) . This study documented significantly greater amounts of immunoreactive alkaline phosphatase protein in strain LH617 than in strains bearing the PagC-alkaline phosphatase fusion (=10-fold greater) or the PagD-alkaline phosphatase fusion (-3-fold greater). Strain LH610 produced levels of immunoreactive alkaline phosphatase comparable to the two phoP-regulated strains (Fig. 3) . Unlike the alkaline phosphatase fusions to phoP-activated genes C and D, the constitutively expressed random fusion proteins did not in and of themselves attenuate S. typhimurium CS019 (data not shown). To administer numbers of bacteria comparable to those achieved for LH491, the constitutivephoA gene fusions were transduced by utilizing bacteriophage P22 to S. typhimurium SL3261, an attenuated aromatic amino acid auxotrophic strain demonstrated to be an effective vaccine in mice (21) . Fig. 2 compares IgG responses from four alkaline phosphatase fusions, two constitutively expressed and two phoP-regulated. All mice developed comparable IgG responses to S. typhimurium LPS, as measured by ELISA OD units, suggesting that overall immunogenicity of the strains is comparable. However, despite >10-fold higher expression of alkaline phosphatase fusion activity in strain LH617, only the organisms bearing phoP-regulated fusions induced significant antibody against the heterologous antigen.
The magnitude of attenuation of a given vaccine strain has been previously demonstrated to be an important variable affecting immunogenicity, and less-attenuated strains might be anticipated to produce a more vigorous antibody response. We therefore considered the possibility that our results were in some way an artifactual finding related to minor differences in vaccine inocula or inherent differences between the attenuated strain backgrounds utilized in this experiment [two attenuated by virtue of the Pag-alkaline phosphatase fusion proteins (i.p. LD50 105) and two attenuated by virtue of an aromatic amino acid auxotrophy (i.p. LD50 > 106) (21) ]. Therefore, pagD-phoA and the constitutively expressed phoA fusion LH617 were mobilized to the SL3261 strain background and administered i.p. as isogenic strains at 5 x 106 cfu per mouse. Again, both strains effectively induced anti-LPS IgG (mean ELISA OD units ± SEM for five mice receiving 106 cfu per mouse: 617-phoA = 0.265 ± 0.142vs.pagD-phoA = 0.201 ± 0.142;P > 0.05). However, only strains bearingphoP-regulated fusions were able to effectively induce an antibody response to the model heterologous antigen (ELISA OD units: 617-phoA = 0.063 ± 0.014 vs. pagD-phoA = 0.235 ± 0.145; P < 0.05). In this experiment, despite greater overall attenuation of the pagD-phoA strain (a result of both the amino acid auxotrophy plus the pagD-phoA gene fusion) only the phoP-regulated fusion antigen effectively elicited a humoral response. These data show that phoP regulation, rather than degree of attenuation, is responsible for the enhanced immunogenicity of our model antigen vaccine strains.
Other environmentally regulated promotors postulated to be expressed in vivo, including those induced by low iron concentrations or anaerobiasis, have been utilized for expression of heterologous antigens in plasmid expression systems in Salmonella (3, 35) . Therefore, as another control, Shiga-like toxin I-B (SLT-IB) expressed under control of an ironregulated promotor was integrated at the pagC chromosomal locus in strain SL3261. Although detectable SLT-IB antigen and appropriate regulation by manipulation of iron concentrations were demonstrable by Western blot analysis, no humoral response to SLT-IB was detectable in mice immunized orally or parenterally with SL3261 carrying this nonphoP-regulated SLT-IB gene (data not shown).
Application to SalmoneUla typhi. Other studies of potential human Salmonella vaccine vectors have utilized attenuated strains of S. typhi. Application of an expression system based upon gene fusions between pagC and clinically relevant heterologous antigens in S. typhi would be contingent upon the presence ofpagC in this organism. In addition, the absence of this locus in human commensals and enteric pathogens would minimize the possibility of recombination events reconstituting a wild-type pagC locus. Therefore, the conservation of pagC sequences among other Enterobacteraceae (Shigella flexneri, Klebsiella pneumoniae, Citrobacter freundii, Campylobacter fetus, Vibrio cholerae, Yersinia enterocolitica, and E. coli) and three other serotypes of Salmonella (Salmonella enteritidis, Salmonella paratyphi A, and S. typhi LT2) was evaluated by using Southern blot hybridization analysis. pagC appeared to be present in all Salmonella serotypes tested but not in the other bacteria evaluated (data not shown). We have used pVAC468 to create thepagCA490 allele in S. typhi 522Ty (36) , demonstrating that sequence homology between S. typhimurium and S. typhi at this locus is adequate for facile transfer of fusion antigen genes to potential human vaccine strains. (7); minimal or no antibody responses were achieved to heterologous antigens expressed from single chromosomal copies (2, (7) (8) (9) . Here we have shown that foreign antigen expression driven by macrophage-inducible promotors leads to a dramatic humoral response to an antigen expressed from a single chromosomal copy. Our results utilizing Pag-alkaline phosphatase fusion antigens are comparable to previously published murine data for multicopy plasmid-encoded heterologous antigens (3) (4) (5) and superior to those for single chromosomal copies of malarial and bacterial antigens (7) (8) (9) . In our experiments, even 3-to 10-fold greater constitutive expression was unable to induce humoral responses approaching those induced by phoP-regulated expression. Further study will be needed to determine whether cell-mediated and mucosal immunity are as effectively stimulated by this method of antigen expression. The exact reason for this enhanced humoral immune response is not yet clear. It is possible that our expression system may dramatically increase the effective antigen concentration in vivo, perhaps by prolonged or enhanced transcriptional activation. We hypothesize that the intracellular location and timing of antigen expression may be critical variables that overcome the need for large amounts of constitutively expressed antigen. Extension of this phoPregulated antigen expression system to relevant bacterial and viral antigens should provide efficacious vaccines. Furthermore, our findings validate the emerging concept that bacterial genes expressed within mammalian cells are optimal targets for development of drugs and vaccines.
DISCUSSION

